• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, August 3, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Study may lead to better breast cancer drugs

Bioengineer by Bioengineer
August 9, 2016
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Biomedical scientists have revealed the inner workings of a group of proteins that help to switch critical genes on and off during blood-cell production, in a finding that could lead to the development of new and improved cancer drugs.

One of the proteins involved is linked to breast cancer, which is the most common cancer for women and kills more than half a million women around the world each year. Existing breast cancer treatments do not target this protein specifically.

Researcher Dr Daniel Ryan from The Australian National University (ANU) said the study could help explain how existing breast-cancer drugs work inside human cells.

“There are treatments for breast cancer which are in use today that are effective but we still don’t know how they work,” said Dr Ryan, from the John Curtin School of Medical Research.

“This research shines a light on an important set of proteins that could be targeted by these drugs and superior treatments yet to be developed.”

The research is part of an international collaboration – involving ANU, the University of Sydney and The University of Pennsylvania in the US – that seeks to understand the mechanisms for gene regulation, particularly in relation to diseases such as cancer and blood disorders.

“By creating better targeted treatments for breast cancer and other serious diseases, we’ll have better outcomes for patients because we’ll be able to reduce toxicity and the risk of drug resistance,” Dr Ryan said.

The research team described how a special group of proteins form into an enzyme that turns genes on and off to produce essential elements in the body, such as blood cells and stem cells.

“This enzyme is like a car and the proteins are the different parts that are used to make it. By knowing how these parts fit together, we can understand how the car works and hence we’re in a better to position to fix it when something goes wrong,” Dr Ryan said.

“We still need to pull the enzyme apart and explore the interactions between the various proteins involved to really grapple with this complex molecular machinery.

“Our ongoing research will help to advance our knowledge of how genes are regulated – a phenomenon that is not only vital to normal functions in the body, but also a key factor in many diseases.”

###

The study was supported by funding from the Australian Research Council and the National Health and Medical Research Council of Australia.

It was published in the Journal of Biological Chemistry: http://www.jbc.org/content/291/30/15853.short

Media Contact

Dr. Daniel Ryan
[email protected]
61-261-252-549
@ANUmedia

http://www.anu.edu.au/media

The post Study may lead to better breast cancer drugs appeared first on Scienmag.

Share22Tweet8Share2ShareShareShare2

Related Posts

blank

Cognitive Dysfunction, Depression Linked in Chemotherapy Patients

August 3, 2025
blank

MLH1 and GPRC5C: Prognostic Markers in Liver Cancer

August 3, 2025

Whole Brain Radiotherapy vs. Integrated Boost Efficiency

August 3, 2025

Intrapleural Anti-VEGF Boosts Nab-Paclitaxel Efficacy

August 2, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • Neuropsychiatric Risks Linked to COVID-19 Revealed

    46 shares
    Share 18 Tweet 12
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12
  • Study Reveals Beta-HPV Directly Causes Skin Cancer in Immunocompromised Individuals

    38 shares
    Share 15 Tweet 10

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Neural Filter Enhances ECMO Heartbeat Synchronization

Cognitive Dysfunction, Depression Linked in Chemotherapy Patients

Dietary Fat Type Shapes Anti-Tumor Immunity in Obese Mice

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.